LARVOL shared a post on X:
“SABCS 2025 abstracts are out!
Explore more insights and data from SABCS25.”
Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, Visiting Professor at McGill University, shared this post, adding:
“At SABCS25, we’ll present Cohort C of DATO-Base, academic IST, and the first prospective trial of Dato-DXd in patients with LMD from HER2-MBC.
LANO ORR 30%, mOS 4.7 months but >1 year in ADC-naive pts, benefit on neurological symptoms.
Selected for poster display.
Join us to discuss!”
More posts featuring LARVOL.
